ORIGINAL RESEARCH
Accepted on 12 Aug 2025
Phytochemical Combinations of Lichen Evernia prunastri (L.) Ach reduce Drug Resistance to Temozolomide but not to Paclitaxel in vitro
doi 10.3389/fphar.2025.1633978
- 179 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Combination Therapies in Cancer Treatment: Enhancing Efficacy and Reducing Resistance
Combination Therapies in Cancer Treatment: Enhancing Efficacy and Reducing Resistance
8,630
Total downloads
38k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 23 Jul 2025
CDFA: Calibrated deep feature aggregation for screening synergistic drug combinations
doi 10.3389/fphar.2025.1608832
- 622 views
CLINICAL TRIAL
Published on 10 Jun 2025
Clinical outcomes of DNA-damaging agents and DNA damage response inhibitors combinations in cancer: a data-driven review
doi 10.3389/fonc.2025.1577468
- 1,381 views
MINI REVIEW
Published on 05 Jun 2025
Chemotherapy-induced immunogenic cell death in combination with ICIs: a brief review of mechanisms, clinical insights, and therapeutic implications
doi 10.3389/fphar.2025.1572195
- 1,531 views
- 2 citations
ORIGINAL RESEARCH
Published on 30 May 2025
Real-world analysis of immunochemotherapy in recurrent small-cell lung cancer: opportunities for second-line approaches
doi 10.3389/fphar.2025.1591643
- 1,032 views
ORIGINAL RESEARCH
Published on 19 May 2025
Iodine-131 induces ferroptosis and synergizes with sulfasalazine in differentiated thyroid cancer cells via suppressing SLC7A11
doi 10.3389/fonc.2025.1580828
- 1,296 views
REVIEW
Published on 30 Apr 2025
Nanotechnology-driven strategies in postoperative cancer treatment: innovations in drug delivery systems
doi 10.3389/fphar.2025.1586948
- 1,324 views
- 1 citation
ORIGINAL RESEARCH
Published on 17 Apr 2025
Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma
doi 10.3389/fphar.2025.1571786
- 1,422 views
ORIGINAL RESEARCH
Published on 27 Mar 2025
Enhancing survival outcomes in unresectable hepatocellular carcinoma: a prospective cohort study on the effects of Huaier granules with targeted therapy plus immunotherapy
doi 10.3389/fphar.2025.1529010
- 1,137 views
ORIGINAL RESEARCH
Published on 25 Mar 2025
Milciclib-mediated CDK2 inhibition to boost radiotherapy sensitivity in colorectal cancer
doi 10.3389/fphar.2025.1557925
- 1,396 views
ORIGINAL RESEARCH
Published on 24 Mar 2025
Efficacy and safety of PD-1/PD-L1 inhibitors combined with tyrosine kinase inhibitors as first-line treatment for hepatocellular carcinoma: a meta-analysis and trial sequential analysis of randomized controlled trials
doi 10.3389/fphar.2025.1535444
- 1,412 views
REVIEW
Published on 10 Mar 2025
TCR-T cell therapy for solid tumors: challenges and emerging solutions
doi 10.3389/fphar.2025.1493346
- 3,934 views
- 2 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore